Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2002 Nov 13;33(1):17–28. doi: 10.1016/0165-5728(91)90030-B

Interleukin-1β decreases HLA class II expression on a glioblastoma multiforme cell line

Elliot P Cowan 1,∗, Michael L Pierce 1, Suhayl Dhib-Jalbut 1,∗
PMCID: PMC7119491  PMID: 1711536

Abstract

Antigens encoded within the major histocompatibility complex (MHC) are not normally expressed in the central nervous system (CNS), but can be induced by treatment with interferon-γ (IFN-γ). Other cytokines released during an inflammatory process can potentially influence MHC expression as well. One cytokine of interest is interleukin-1 (IL-1), an immunoregulatory polypeptide that is produced by macrophages and also by cells in the CNS. In this study, the effedt of IL-1β on MHC expression in a human glioblastoma multiforme cell line, U-105 MG, has been examined. Treatment of U-105 MG with 10 U IL-1β/ml for a period of 5 days resulted in a decrease in constitutive cell surface HLA class II expression and limited the induction of class II by IFN-γ. This effect was also observed on steady-state levels of class II RNA and could be neutralized with antibodies to IL-1β. All class II transcripts examined (HLA-DR, -DQ, and -DP α and β) were affected. Class I expression was only marginally changed by IL-1β treatment. A minimal concentration of 1 U IL-1β/ml was required to reduce class II expression and a kinetics experiment indicated that U-105MG must be treated for at least 4 days with IL-1β for a decrease in class II expression to be observed. This study suggests that IL-1 may play a role in limiting immunoreactivity in the CNS by limiting class II induction.

Keywords: Interleukin-1, HLA class II genes, Glioblastoma multiforme

References

  1. Auffray C., Lillie J.W., Arnot D., Grossberger D., Kappes D., Strominger J.L. Isotypic and allotypic variation of human class II histocompatibility antigen alphachain genes. Nature. 1984;308:327–333. doi: 10.1038/308327a0. [DOI] [PubMed] [Google Scholar]
  2. Berkenbosch F., Oers J.V., del Rey A., Tilders F., Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science. 1987;238:524–526. doi: 10.1126/science.2443979. [DOI] [PubMed] [Google Scholar]
  3. Bernton E.W., Beach J.E., Holaday J.W., Smallridge R.C., Fein H.G. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science. 1987;238:519–521. doi: 10.1126/science.2821620. [DOI] [PubMed] [Google Scholar]
  4. Besedovsky H., del Rey A., Sorkin E., Dinarello C.A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 1986;233:652–654. doi: 10.1126/science.3014662. [DOI] [PubMed] [Google Scholar]
  5. Bigner D.D., Bigner S.H., Ponten J., Westermark B., Mahaley M.S., Ruoslahti E., Herschman H., Eng L.F., Wikstrand C.F. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived form human gliomas. J. Neuropathol. Exp. Neurol. 1981;40:201–229. doi: 10.1097/00005072-198105000-00001. [DOI] [PubMed] [Google Scholar]
  6. Billiau A., Van Damme J., Opdenakker G., Fibbe W.E., Falkenburg J.H.F., Content J. Interleukin-1 as a cytokine inducer. Immunobiology. 1986;172:323–335. doi: 10.1016/S0171-2985(86)80114-0. [DOI] [PubMed] [Google Scholar]
  7. Bottazzo G.F., Pujol-Borrell R., Hanafusa T., Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in the induction of endocrine autoimmunity. Lancet. 1983;ii:1115–1119. doi: 10.1016/s0140-6736(83)90629-3. [DOI] [PubMed] [Google Scholar]
  8. Breder C.D., Dinarello C.A., Saper C.B. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science. 1988;240:321–324. doi: 10.1126/science.3258444. [DOI] [PubMed] [Google Scholar]
  9. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987;162:156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  10. Curtis B.M., Widmer M.B., DeRoos P., Quarnstrom E.E. IL-1 and its receptor are translocated to the nucleus. J. Immunol. 1990;144:1295–1303. [PubMed] [Google Scholar]
  11. Dhib-Jalbut S., McFarlin D.E. Macrophages, microglia, and other antigen presenting cells in neurological disorders. Prog. Neuroendocr. Immunol. 1989;2:86–95. [Google Scholar]
  12. Dhib-Jalbut S., Kufta C.V., Flerlage M., Shimojo N., McFarland H.F. Adult human glial cells can present target antigens to HLA-restricted cytotoxic T-cells. J. Neuroimmunol. 1990;29:203–211. doi: 10.1016/0165-5728(90)90163-H. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dinarello C.A. Biology of interleukin 1. FASEB J. 1988;2:108–115. [PubMed] [Google Scholar]
  14. Fertsch D., Schoenberg D.R., Germain R.N., Tou J.Y.L., Vogel S.N. Induction of macrophage Ia antigen expression by rIFN-γ and down-regulation by IFN-α/β and dexamethasone are mediated by changes in steady state levels of Ia mRNA. J. Immunol. 1987;139:244–249. [PubMed] [Google Scholar]
  15. Fontana A., Grob P. Astrocyte-derived interleukin-1-like factors. Lymphokine Res. 1984;3:11–16. [PubMed] [Google Scholar]
  16. Fontana A., Fierz W., Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature. 1984;307:273–276. doi: 10.1038/307273a0. [DOI] [PubMed] [Google Scholar]
  17. Fontana A., Frei K., Bodmer S., Hofer E. Immune-mediated encephalitis: on the role of antigen-presenting cells in brain tissue. Immunol. Rev. 1987;100:185–201. doi: 10.1111/j.1600-065X.1987.tb00532.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Frohman E., van den Noort S., Gupta S. Astrocytes and intracerebral immune responses. J. Clin. Immunol. 1989;9:1–9. doi: 10.1007/BF00917121. [DOI] [PubMed] [Google Scholar]
  19. Giulian D., Lachman L.B. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science. 1985;228:497–499. doi: 10.1126/science.3872478. [DOI] [PubMed] [Google Scholar]
  20. Giulian D., Baker T.J., Shih L.N., Lachman L.B. Interleukin-1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 1986;164:594–604. doi: 10.1084/jem.164.2.594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Giulian D., Woodward J., Young D.G., Krebs J.F., Lachman L.B. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neurovascularization. J. Neurosci. 1988;8:2485–2490. doi: 10.1523/JNEUROSCI.08-07-02485.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hertz L., McFarlin D.E., Waksman B.H. Astrocytes: auxiliary cells for immune responses in the central nervous system? Immunol. Today. 1990;11:265–268. doi: 10.1016/0167-5699(90)90106-j. [DOI] [PubMed] [Google Scholar]
  23. Hoffman F.M., Von Hanwebr R.I., Dinarello C.A., Mizel S.B., Hinton D., Merrill J.E. Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J. Immunol. 1986;136:3239–3245. [PubMed] [Google Scholar]
  24. Johnson W.J., Kelley A., Connor J.R., Dalton B.J., Meunier P.C. Inhibition of IFN-γ-induced Ia antigen expression on synovial fibroblasts by IL-1. J. Immunol. 1989;143:1614–1618. [PubMed] [Google Scholar]
  25. Massa P.T., Ter Meulen V. Analysis of Ia induction on Lewis rat astrocytes in vitro by virus particles and bacterial adjuvants. J. Neuroimmunol. 1987;13:259–271. doi: 10.1016/0165-5728(87)90062-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Massa P.T., Brinkmann R., Ter Meulen V. Inducibility of Ia antigen on astrocytes by murine coronavirus JHM is rat strain dependent. J. Exp. Med. 1987;166:259–264. doi: 10.1084/jem.166.1.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. McCarron R.M., Kempski O., Spatz M., McFarlin D.E. Presentation of myelin basic protein by murine cerebral vascular endothelial cells. J. Immunol. 1985;134:3100–3103. [PubMed] [Google Scholar]
  28. Mokhtarian F., McFarlin D.E., Raine C.S. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic-relapsing demyelinating disease in mice. Nature. 1984;309:356–358. doi: 10.1038/309356a0. [DOI] [PubMed] [Google Scholar]
  29. Prineas J.W. The neuropathology of multiple sclerosis. In: Koetsier K.C., editor. Elsevier; Amsterdam: 1985. pp. 213–257. (Handbook of Clinical Neurology). [Google Scholar]
  30. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science. 1987;238:522–524. doi: 10.1126/science.2821621. [DOI] [PubMed] [Google Scholar]
  31. Schwartz R.H. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu. Rev. Immunol. 1985;3:237–261. doi: 10.1146/annurev.iy.03.040185.001321. [DOI] [PubMed] [Google Scholar]
  32. Sekaly R.P., Tonelle C., Strubin M., Mach B., Long E.O. Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain. J. Exp. Med. 1986;164:1490–1504. doi: 10.1084/jem.164.5.1490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Shirakawa F., Yamashita U., Chedid M., Mizel S.B. Vol. 85. 1988. Cyclic AMP — an intracellular second messenger for interleukin 1; pp. 8201–8205. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Snyder D.R., Unanue E.R. Corticosteroids inhibit murine macrophage Ia expression and interleukin production. J. Immunol. 1982;129:1803–1805. [PubMed] [Google Scholar]
  35. Snyder D.S., Beller D.I., Unanue E.R. Prostaglandins modulate macrophage Ia expression. Nature. 1982;299:163–165. doi: 10.1038/299163a0. [DOI] [PubMed] [Google Scholar]
  36. Sun D., Wekerle H. Ia restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes. Nature. 1986;320:70–72. doi: 10.1038/320070a0. [DOI] [PubMed] [Google Scholar]
  37. Sundar S.K., Becker K.J., Cierpial M.A., Carpenter M.D., Rankin L.A., Fleener S.L., Ritchie J.C., Simon P.E., Weiss J.M. Vol. 86. 1989. Intracerebral infusion of interleukin-1 rapidly decreases peripheral cellular immune responses; pp. 6398–6402. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Takiguchi M., Ting J.P.-Y., Buessow S.C., Boyer C., Gillespie Y., Frelinger J.A. Response of glioma cells to interferon-γ: increase in class II RNA, protein and mixed lymphocyte reaction-stimulating activity. Eur. J. Immunol. 1985;15:809–814. doi: 10.1002/eji.1830150813. [DOI] [PubMed] [Google Scholar]
  39. Tanaka M., McCarron R.M. The inhibitory effect of tumor necrosis factor and interleukin-1 by interferon-γ on endothelial cells from murine central nervous system microvessels. J. Neuroimmunol. 1990;27:209–215. doi: 10.1016/0165-5728(90)90071-t. [DOI] [PubMed] [Google Scholar]
  40. Tonnelle C., DeMars R., Long E.O. DOβ: a new β chain gene in HLA-D with a distinct regulation of expression. EMBO J. 1985;4:2839–2847. doi: 10.1002/j.1460-2075.1985.tb04012.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Townsend A., Bodmer H. Antigen recognition by class I-restricted lymphocytes. Annu. Rev. Immunol. 1989;7:601–624. doi: 10.1146/annurev.iy.07.040189.003125. [DOI] [PubMed] [Google Scholar]
  42. Traugott U., Lebon P. Interferon γ and Ia are present on astrocytes in active chronic multiple sclerosis lesions. J. Neurol. Sci. 1988;84:257–264. doi: 10.1016/0022-510x(88)90130-x. [DOI] [PubMed] [Google Scholar]
  43. Traugott U., Scheinberg L.C., Raine C.S. On the presence of Ia positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J. Neuroimmunol. 1985;8:1–14. doi: 10.1016/s0165-5728(85)80043-6. [DOI] [PubMed] [Google Scholar]
  44. Unanue E.R. The major histocompatibility complex and immunogenetics: antigen presenting function of the macrophage. Annu. Rev. Immunol. 1984;2:395–428. doi: 10.1146/annurev.iy.02.040184.002143. [DOI] [PubMed] [Google Scholar]
  45. Williams K., Hart D., Fabre J., Morris P. Distribution and quantitation of HLA-A, B, C, and DR (Ia) antigens on human kidney and other tissues. Transplantation. 1980;29:274–279. doi: 10.1097/00007890-198004000-00002. [DOI] [PubMed] [Google Scholar]
  46. Zinkernagel R.M., Doherty P.C. Restriction of in vivo T-cell mediated cytotoxicity in lymphocytic choriomeningitis with a syngeneic or semiallogeneic system. Nature. 1974;248:701–702. doi: 10.1038/248701a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neuroimmunology are provided here courtesy of Elsevier

RESOURCES